These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22222037)

  • 1. Tricyclic 3,4-dihydropyrimidine-2-thione derivatives as potent TRPA1 antagonists.
    Gijsen HJ; Berthelot D; De Cleyn MA; Geuens I; Brône B; Mercken M
    Bioorg Med Chem Lett; 2012 Jan; 22(2):797-800. PubMed ID: 22222037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 7-Substituted-pyrrolo[3,2-d]pyrimidine-2,4-dione derivatives as antagonists of the transient receptor potential ankyrin 1 (TRPA1) channel: a promising approach for treating pain and inflammation.
    Baraldi PG; Romagnoli R; Saponaro G; Aghazadeh Tabrizi M; Baraldi S; Pedretti P; Fusi C; Nassini R; Materazzi S; Geppetti P; Preti D
    Bioorg Med Chem; 2012 Mar; 20(5):1690-8. PubMed ID: 22325155
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of novel azabenzofuran TRPA1 antagonists as in vivo tools.
    Copeland KW; Boezio AA; Cheung E; Lee J; Olivieri P; Schenkel LB; Wan Q; Wang W; Wells MC; Youngblood B; Gavva NR; Lehto SG; Geuns-Meyer S
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3464-8. PubMed ID: 24953819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRPA1 antagonists as potential analgesic drugs.
    Andrade EL; Meotti FC; Calixto JB
    Pharmacol Ther; 2012 Feb; 133(2):189-204. PubMed ID: 22119554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and pharmacological evaluation of PF-4840154, a non-electrophilic reference agonist of the TrpA1 channel.
    Ryckmans T; Aubdool AA; Bodkin JV; Cox P; Brain SD; Dupont T; Fairman E; Hashizume Y; Ishii N; Kato T; Kitching L; Newman J; Omoto K; Rawson D; Strover J
    Bioorg Med Chem Lett; 2011 Aug; 21(16):4857-9. PubMed ID: 21741838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxime derivatives related to AP18: Agonists and antagonists of the TRPA1 receptor.
    Defalco J; Steiger D; Gustafson A; Emerling DE; Kelly MG; Duncton MA
    Bioorg Med Chem Lett; 2010 Jan; 20(1):276-9. PubMed ID: 19945872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of [6]-gingerol analogues as transient receptor potential channel TRPV1 and TRPA1 modulators.
    Morera E; De Petrocellis L; Morera L; Moriello AS; Nalli M; Di Marzo V; Ortar G
    Bioorg Med Chem Lett; 2012 Feb; 22(4):1674-7. PubMed ID: 22257892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery, optimization, and biological evaluation of 5-(2-(trifluoromethyl)phenyl)indazoles as a novel class of transient receptor potential A1 (TRPA1) antagonists.
    Rooney L; Vidal A; D'Souza AM; Devereux N; Masick B; Boissel V; West R; Head V; Stringer R; Lao J; Petrus MJ; Patapoutian A; Nash M; Stoakley N; Panesar M; Verkuyl JM; Schumacher AM; Petrassi HM; Tully DC
    J Med Chem; 2014 Jun; 57(12):5129-40. PubMed ID: 24884675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N-1-Alkyl-2-oxo-2-aryl amides as novel antagonists of the TRPA1 receptor.
    Vallin KS; Sterky KJ; Nyman E; Bernström J; From R; Linde C; Minidis AB; Nolting A; Närhi K; Santangelo EM; Sehgelmeble FW; Sohn D; Strindlund J; Weigelt D
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5485-92. PubMed ID: 22868228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discovery of a series of aryl-N-(3-(alkylamino)-5-(trifluoromethyl)phenyl)benzamides as TRPA1 antagonists.
    Laliberté S; Vallée F; Fournier PA; Bedard L; Labrecque J; Albert JS
    Bioorg Med Chem Lett; 2014 Jul; 24(14):3204-6. PubMed ID: 24880903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse monoclonal antibodies to transient receptor potential ankyrin 1 act as antagonists of multiple modes of channel activation.
    Lee KJ; Wang W; Padaki R; Bi V; Plewa CA; Gavva NR
    J Pharmacol Exp Ther; 2014 Aug; 350(2):223-31. PubMed ID: 24893987
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Amino-4-arylthiazole compounds as TRPA1 antagonists (WO 2012085662): a patent evaluation.
    De Petrocellis L; Schiano Moriello A
    Expert Opin Ther Pat; 2013 Jan; 23(1):119-47. PubMed ID: 23126422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of substituted 5-(1,2,4-oxadiazol-5-yl)-3,4-dihydropyrimidine-2(1H)-thiones.
    Kharchenko JV; Detistov OS; Orlov VD
    J Comb Chem; 2009 Mar; 11(2):216-9. PubMed ID: 19133738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the biology and medicinal chemistry of TRPA1.
    Rech JC; Eckert WA; Maher MP; Banke T; Bhattacharya A; Wickenden AD
    Future Med Chem; 2010 May; 2(5):843-58. PubMed ID: 21426205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained TRPA1 activation in vivo.
    Koivisto A
    Acta Physiol (Oxf); 2012 Feb; 204(2):248-54. PubMed ID: 21518269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tetrahydro-β-carboline derivatives targeting fatty acid amide hydrolase (FAAH) and transient receptor potential (TRP) channels.
    Ortar G; De Petrocellis L; Moriello AS; Allarà M; Morera E; Nalli M; Di Marzo V
    Bioorg Med Chem Lett; 2013 Jan; 23(1):138-42. PubMed ID: 23206861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of a Novel Quinazolinone-Based Series of Transient Receptor Potential A1 (TRPA1) Antagonists Demonstrating Potent in Vivo Activity.
    Schenkel LB; Olivieri PR; Boezio AA; Deak HL; Emkey R; Graceffa RF; Gunaydin H; Guzman-Perez A; Lee JH; Teffera Y; Wang W; Youngblood BD; Yu VL; Zhang M; Gavva NR; Lehto SG; Geuns-Meyer S
    J Med Chem; 2016 Mar; 59(6):2794-809. PubMed ID: 26942860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardamonin, a Novel Antagonist of hTRPA1 Cation Channel, Reveals Therapeutic Mechanism of Pathological Pain.
    Wang S; Zhai C; Zhang Y; Yu Y; Zhang Y; Ma L; Li S; Qiao Y
    Molecules; 2016 Aug; 21(9):. PubMed ID: 27589700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HC-030031, a TRPA1 selective antagonist, attenuates inflammatory- and neuropathy-induced mechanical hypersensitivity.
    Eid SR; Crown ED; Moore EL; Liang HA; Choong KC; Dima S; Henze DA; Kane SA; Urban MO
    Mol Pain; 2008 Oct; 4():48. PubMed ID: 18954467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging agent of a TRPA1 inhibitor.
    Malmquist J; Bernlind A; Lindberg S
    J Labelled Comp Radiopharm; 2013; 56(9-10):536-7. PubMed ID: 24285533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.